Anika Therapeutics Stock Price on November 8, 2024
| ANIK Stock | USD 17.00 0.04 0.23% |
Below is the normalized historical share price chart for Anika Therapeutics extending back to May 03, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Anika Therapeutics stands at 17.00, as last reported on the 15th of November 2024, with the highest price reaching 17.19 and the lowest price hitting 16.50 during the day.
If you're considering investing in Anika Stock, it is important to understand the factors that can impact its price. Anika Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Anika Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anika Therapeutics' Standard Deviation of 4.21, mean deviation of 1.85, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide.
Capital Stock is expected to rise to about 158.6 K this year, although the value of Total Stockholder Equity will most likely fall to about 120.9 M. . At this time, Anika Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 1.73 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (176.45). Anika Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 1993 | 200 Day MA 25.0978 | 50 Day MA 23.1036 | Beta 0.857 |
Anika |
Sharpe Ratio = -0.1427
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ANIK |
Estimated Market Risk
| 4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.61 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Anika Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anika Therapeutics by adding Anika Therapeutics to a well-diversified portfolio.
Price Book 1.3875 | Enterprise Value Ebitda (72.65) | Price Sales 1.5166 | Shares Float 10.6 M | Wall Street Target Price 26.5 |
Related Headline
Axogen Headline on 8th of November 2024
AxoGen Reports Strong Q3 2024 Revenue Growth by finance.yahoo.com
AxoGen just unveiled an update. Axogen, Inc., a leader in peripheral nerve repair solutions, reported a notable 17.9 percent revenue increase for Q3 2024 at 48.6 million, alongside a decrease in net loss to 1.9 million from 4.1 million in the previous year. The companys strategic advancements include FDA acceptance of its Biologics License Application for Avance Nerve Graft and promising engagement at industry events. Axogen aims to hit the high end of its revenue and gross margin guidan
Anika Therapeutics Valuation on November 8, 2024
It is possible to determine the worth of Anika Therapeutics on a given historical date. On November 8, 2024 Anika was worth 17.1 at the beginning of the trading date compared to the closed value of 17.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Anika Therapeutics stock. Still, in general, we apply an absolute valuation method to find Anika Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anika Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Anika Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 17.13 | 17.34 | 16.93 | 17.23 | 129,142 | |
11/08/2024 | 17.10 | 17.50 | 16.75 | 17.26 | 128,753 |
| 17.28 | 17.85 | 16.96 | 17.07 | 106,751 |
| Backtest Anika Therapeutics | | | Anika Therapeutics History | | | Anika Therapeutics Valuation | Previous | Next |
Anika Therapeutics Trading Date Momentum on November 8, 2024
| On November 11 2024 Anika Therapeutics was traded for 17.07 at the closing time. The top price for the day was 17.85 and the lowest listed price was 16.96 . The trading volume for the day was 106.8 K. The trading history from November 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.10% . The overall trading delta against the current closing price is 0.41% . |
Anika Therapeutics Fundamentals Correlations and Trends
By evaluating Anika Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Anika Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Anika financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Anika Therapeutics Stock history
Anika Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anika is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anika Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anika Therapeutics stock prices may prove useful in developing a viable investing in Anika Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.7 M | 12.7 M | |
| Net Loss | -17.1 M | -16.2 M |
Anika Therapeutics Quarterly Net Working Capital |
|
Anika Therapeutics Stock Technical Analysis
Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Anika Therapeutics Period Price Range
Low | November 15, 2024
| High |
0.00 | 0.00 |
Anika Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Anika Therapeutics November 15, 2024 Market Strength
Market strength indicators help investors to evaluate how Anika Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anika Therapeutics shares will generate the highest return on investment. By undertsting and applying Anika Therapeutics stock market strength indicators, traders can identify Anika Therapeutics entry and exit signals to maximize returns
Anika Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Anika Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Anika Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anika to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.21) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (6.64) | Revenue Per Share 11.139 | Quarterly Revenue Growth (0.07) | Return On Assets (0.04) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.